Pharming Group N.V. provided sales guidance for the remainder of 2020. For the remainder of 2020, the company expects continued sales growth versus last year, driven by increasing patient numbers and despite competitive pressure, whilst remaining cognisant of the macro-environment and uncertainty around COVID-19.